Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Babaodan capsules for postoperative quality of life in cholelithiasis
ChiCTR-IPR-17013290Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of Babaodan and glutathione in cholelithiasis (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Liver function, Blood coagulation function and 4 more. Started Dec 2016; status: recruiting.
02
Drugs
Babaodanglutathione
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR-IPR-17013290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013290.